Healum Personalised Care – Free Licenses Available for GPs

Funding has recently been made available by the Small Business Research Initiative (SBRI) for Healum licenses for up to 30 GP practices in south London for one year.

Healum software is interoperable with EMIS and is designed to help patients to make healthy choices which minimise their risk of cardiovascular disease, and reduce pressure on workforces. It empowers staff and patients to work together by providing educational content, self-management tools and patient care plans.

The care plans are linked to the GP health record and combine clinical and non-clinical recommendations as part of a shared decision-making process that involves staff from across each practice, including GPs, nurses, pharmacists, healthcare assistants, health and wellbeing coaches and social prescribing link workers.

There are no additional or hidden costs for practices using the system. They are fully covered by the project funding. Practices using Healum will help to shape its development and content, to help it meet the needs of GPs and patients.

Oliver Brady, HIN Programme Director for Long-term Conditions, said:

“I am delighted to work with Healum again, this time to support the adoption and spread of their innovative system tailored to the needs of people at risk of CVD and the Healthcare Professionals responsible for their care.” 

You can find out more about what Healum software can do for your practice on the Healum website. To register your interest please contact Alice Holden at Healum. The HIN are supporting this project as part of the SBRI grant so you can also get in touch with Kristina.

Please share with any practices who may be interested.

Working Together to Prevent Cardiovascular Disease

Supporting the NHS workforce to develop skills and drive improvement is one of the HIN’s top priorities. As part of this we set up the Cardiovascular Disease (CVD) Prevention Fellowship and now we’re sharing guidance to help other organisations looking to run similar programmes. Sophie Mizen, Project Manager for the Fellowship Programme, writes about what we learnt from running the programme and how you help spread the word.

We set up the Cardiovascular Disease (CVD) Prevention Fellowship to address an area which is a top priority for the NHS. There are six million people in the UK with CVD and taking action to prevent it is the best way of reducing harm and saving lives. With a total cost to the NHS of £16bn per year, it’s also a more efficient way to tackle the problem than treating CVD at a later stage.

CVD Fellowship Stats

  • 85 participants from all 12 south London boroughs
  • 19 projects in hypertension impacting 21 GP surgeries
  • 14 projects in lipids impacting 22 GP surgeries
  • Three projects in familiar hypercholesterolaemia impacting seven GP surgeries
  • Four projects in atrial fibrillation impacting eight GP surgeries
  • 98 per cent of participants feel more confident in delivering care to patients at risk of CVD
  • 96 per cent are more confident in supporting their colleagues with CVD care
  • 95 per cent think patients at risk of CVD have benefited as a result

The Fellowship is one of a number of collaborative learning opportunities provided by the HIN to develop skills in the workforce and support the delivery of improvement projects aligned to health and care priorities. This supports our objectives of developing the skills needed to power health and care systems of the future, as well as making an immediate positive impact in areas of need.

The CVD Prevention Fellowship ran between April and November 2022, and included clinical webinars from specialists in the field, and collaborative quality improvement (QI) sessions where fellows could gain new skills, share learning and work on their own QI projects. The Fellowship was open to all health care professionals in primary care in south London.

Running the programme presented some challenges – not least because the number of participants was higher than we expected with over 100 initially expressing interest! We also know that clinicians tend to have very limited time, and while the Fellowship was free to join, we were not able to fund back-fill for time taken out of work. As such we had to keep the time commitment to a minimum, and were flexible in our approach to collecting progress updates.

We also adapted our approach to communication channels as we went. Our used of continuous feedback helped us listen to Fellows' needs and adapt the programme accordingly. As such, we switched our focus from quality improvement theory to practical troubleshooting when we realised this would be more beneficial to the Fellows and a more productive use of their time. We also incorporated some additional sessions such as a webinar on behaviour change in CVD and a drop-in clinic with a specialist going through lipids case studies.

The response to the fellowship was overwhelming, with over 80 fellows being upskilled in various areas of CVD and quality improvement. The fellows were required to deliver an improvement project in their practice/primary care network, to apply their new skills and knowledge. As part of the programme 40 quality improvement projects collectively impacting a total of 63 GP practices, representing all 12 boroughs in south London.

Patients positively responded to the work and we received some great feedback on the impact the quality improvement projects had on an individual level:

Thanks for giving me the information about statins. I did not realise that statins had anything to do with protecting the heart. I just thought it was to reduce cholesterol which I have been trying to do by good diet and exercise. Although sometimes I like to enjoy myself a little and eat the unhealthy stuff, I take my atorvastatin daily and I have not felt any side effects. Looking forward to the next blood test.

You can find out more about the patient experience in our case study pack which includes information on all the projects.

Throughout the programme feedback was received on the beneficial impact of education and training. A final feedback survey revealed that 98 per cent of fellows felt more confident delivering care to people at risk of CVD, and 96 per cent said they are supporting colleagues more with CVD prevention. Most importantly, 95% per cent said their at-risk patients have benefited from what they learnt. We also received great feedback from participants – you can find out more in the video below.

We learnt a lot from running the programme and wanted to share this to make it easier for anyone else thinking of running a similar programme. That’s why we’ve put together a guide outlining our approach, learnings and what we would do differently next time. Please share with any individuals or organisations who might be interested.

Find out More

Find out more about the Fellowship and access the resources mentioned in this blog.

Find out more about the CVD Prevention Fellowship.

New Funding to Help Prevent Cardiovascular Disease

Doctor uses stethoscope to monitor heart of patient.

The Small Business Research Initiative (SBRI) has awarded a total of £3.3 million funding to support initiatives designed to tackle cardiovascular disease (CVD) in England. A portion of the national funding will be used to scale up initiatives in two projects to prevent CVD in south London: Healum patient management software and the CVD Prevention Decathlon.

CVD is the area where most lives can be saved by the NHS over the next decade. There are 7.6 million people living with CVD in the UK, and it is a leading cause of premature disability, mortality, and health inequalities, responsible for one in four deaths each year. The UK Health Security Agency estimates that the annual healthcare cost of CVD in England is around £7.4 billion, with an annual cost to the wider economy of £15.8 billion.

SBRI Healthcare, an Accelerated Access Collaborative (AAC) initiative in partnership with the AHSN Network, has awarded a total of £3.3 million to eight late-stage innovations that help detect, prevent and manage CVD.

Healum is a patient management system that connects to patient-facing digital services. It is designed to improve health outcomes and access to care for patients with long-term conditions, supporting them to make the best choices to live healthier, happier lives. The HIN will be supporting the adoption of Healum in primary care across south London.

The CVD Prevention Decathlon provides structured education for those at risk of CVD in order to minimise the risk of developing it. It uses structured learning and physical activity delivered by Xyla; gamification via the Sweatcoin app; and personalised behaviour change videos created by Citizen Communications. Funding has been allocated to support rollout in South West London ICS and evaluate the return on investment from using it. This builds on the successful Diabetes Prevention Decathlon – winner of a 2019 HIN innovation grant – which saw 92 per cent completion rates and an average 45 per cent increase in activity levels among participants.

Ambra Caruso, Senior Programme Manager at the HIN, said: “We are delighted that new funding has been allocated to help tackle CVD in south London. We are looking forward to continuing and expanding our support for Healum and Decathlon to minimise the risk posed by CVD for as many people as possible”.

Chris Gumble, Project Manager for Long Term Conditions and Prevention at the South West London Health and Care Partnership, said: “We are immensely proud to have the ability to deliver the CVD Prevention Decathlon to our local population, and want to thank SBRI Healthcare for awarding us the funding to do so. Having seen the success of the Diabetes Prevention Decathlon over the last few years, we have an amazing new opportunity to expand the offer to those at risk of CVD. In collaboration with the Health Innovation network, the Prevention Decathlon has grown into something special: 700 people this year will have the opportunity to attend the programme over the coming year”

SBRI Healthcare is an Accelerated Access Collaborative (AAC) initiative – a partnership between patient groups, government bodies, industry and the NHS hosted by NHS England – and is delivered in partnership with the AHSN Network.

Matt Whitty, CEO of the AAC, said: “The SBRI Healthcare awards help the NHS to develop new technologies and solutions to address some of the biggest healthcare challenges facing society. We have selected these innovations because they have the potential to make a big difference to patients. By supporting the most promising innovations the NHS will continue to evolve, helping meet more patients’ needs and encouraging more innovators to come forward with ideas that make a difference.”

Find out more about the new funding announcement from SBRI.

Applications open for first ever Cardiovascular Disease Prevention Fellowship Programme

The Health Innovation Network has launched a new Cardiovascular Disease (CVD) Prevention Fellowship Programme to develop clinical skills and knowledge to help improve outcomes for patients across south London who are at risk of CVD.

Did you know?

  • Six million people live with CVD in England
  • CVD results in £16 billion in combined costs every year
  • It causes one death every four minutes
*NICE Impact – Cardiovascular  disease prevention (September 2021)

This free programme is the first of its kind and is aimed at nurses, GPs and pharmacists working in primary care in south London who are keen to develop their skills and knowledge and champion CVD prevention in their practice or wider Primary Care Network.

It is Continuing Professional Development (CPD) accredited and will provide free expert clinical advice and quality improvement support to help fellows become CVD prevention champions. It will also help them identify and implement specific local CVD prevention initiatives in their practice and local area.

Running from April to October 2022 and culminating with a graduation ceremony in November the programme will consist of six monthly lunch time webinars led by experts in a range of areas including lipid management, hypertension and atrial fibrillation. There will also be ongoing Community of Practice sessions and peer to peer networking opportunities.

With six million people living with CVD in England with a combined cost of £16 billion every year improving outcomes for at risk patients is an NHS priority. This programme will help to speed up the adoption of innovative initiatives to help prevent CVD across south London.

Applications for the programme have now closed.

“We are delighted to launch our first ever CVD Prevention Fellowship Programme. Our free programme will be delivered by experts in their field and will arm clinicians with the knowledge, skills and confidence they need to drive forward innovative schemes and make a real difference to patients at risk of CVD in their area.”Oliver Brady, CVD Prevention Programme Director, Health Innovation Network

We're here to help

Get in touch for more information about our CVD team and their projects

Get in touch